Morgan Stanley Burning Rock Biotech LTD Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Oct 17, 2024	BUY	$0.68 - $0.97 $152,239 - $217,164	223,881 New	223,881 $163,000
Q1 2024 Aug 16, 2024	SELL	$0.68 - $0.97 $65,231 - $93,051	-95,929 Reduced 30.0%	223,881 $163,000
Q1 2024 May 15, 2024	SELL	$0.68 - $0.97 $65,231 - $93,051	-95,929 Reduced 30.0%	223,881 $163,000
Q4 2023 Aug 16, 2024	BUY	$0.72 - $1.13 $230,263 - $361,385	319,810 New	319,810 $297,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.13 $47 - $74	-66 Reduced 0.02%	319,810 $297,000
Q3 2023 Nov 15, 2023	SELL	$0.91 - $2.29 $285,603 - $718,716	-313,850 Reduced 49.52%	319,876 $310,000
Q2 2023 Aug 14, 2023	SELL	$2.15 - $3.16 $300,828 - $442,147	-139,920 Reduced 18.09%	633,726 $1.36 Million
Q1 2023 May 15, 2023	SELL	$2.16 - $3.47 $298,868 - $480,126	-138,365 Reduced 15.17%	773,646 $2.17 Million
Q4 2022 Feb 14, 2023	SELL	$1.73 - $2.95 $5,158 - $8,796	-2,982 Reduced 0.33%	912,011 $2.05 Million
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $141,495 - $234,443	-59,203 Reduced 6.08%	914,993 $2.19 Million
Q2 2022 Oct 27, 2022	BUY	$1.75 - $10.44 $154,672 - $922,728	88,384 Added 9.98%	974,196 $2.83 Million
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $154,672 - $922,728	88,384 Added 9.98%	974,196 $2.83 Million
Q1 2022 Oct 27, 2022	SELL	$6.7 - $10.23 $592,172 - $904,168	-88,384 Reduced 9.07%	885,812 $8.23 Million
Q1 2022 May 13, 2022	BUY	$6.7 - $10.23 $2.42 Million - $3.69 Million	361,094 Added 68.82%	885,812 $8.23 Million
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $538,236 - $978,299	57,077 Added 12.21%	524,718 $5 Million
Q3 2021 Nov 15, 2021	BUY	$17.37 - $27.92 $8.12 Million - $13.1 Million	467,641 New	467,641 $8.36 Million

Others Institutions Holding BNR

# of Institutions

Shares Held

21.2K

Call Options Held

Put Options Held

Sc China Holding LTD N/A, K3

21.2K
Shares

$129,393
0.0% of portfolio

View Full List

About Burning Rock Biotech Ltd

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

More about BNR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account